Gregory Demopulos
Chief Executive Officer chez OMEROS CORPORATION
Fortune : 7 M $ au 31/03/2024
Profil
Gregory A.
Demopulos is the Chairman, President & Chief Executive Officer of Omeros Corp., a company he founded in 1994.
He is currently serving as a Director at Onconome, Inc., Tessera, Inc., Northwest NeuroNeighborhood, and Smead Funds Trust.
Dr. Demopulos has an undergraduate degree from Stanford University and a doctorate from Stanford University School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
OMEROS CORPORATION
3,22% | 31/12/2023 | 2 026 986 ( 3,22% ) | 7 M $ | 31/03/2024 |
Postes actifs de Gregory Demopulos
| Sociétés | Poste | Début |
|---|---|---|
| OMEROS CORPORATION | Chief Executive Officer | 16/06/1994 |
Tessera, Inc.
 Tessera, Inc. SemiconductorsElectronic Technology Tessera, Inc. provides packaging solutions for the semiconductor industry. The company was founded on December 16, 1992 and is headquartered in San Jose, CA. | Director/Board Member | - |
Onconome, Inc.
 Onconome, Inc. Medical SpecialtiesHealth Technology Onconome, Inc. provides development and commercialization of innovative biomarkers. It offers biomarkers for the early and accurate detection of prostate, colon and other forms of cancer including lung, breast, liver, pancreatic and stomach. The company was founded by H. Raymond Cairncross in 2001 and is headquartered in Seattle, WA. | Director/Board Member | - |
| Smead Funds Trust | Director/Board Member | - |
| Northwest NeuroNeighborhood | Director/Board Member | - |
Formation de Gregory Demopulos
| Stanford University | Undergraduate Degree |
| Stanford University School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| OMEROS CORPORATION | Health Technology |
| Entreprise privées | 4 |
|---|---|
Onconome, Inc.
Onconome, Inc. Medical SpecialtiesHealth Technology Onconome, Inc. provides development and commercialization of innovative biomarkers. It offers biomarkers for the early and accurate detection of prostate, colon and other forms of cancer including lung, breast, liver, pancreatic and stomach. The company was founded by H. Raymond Cairncross in 2001 and is headquartered in Seattle, WA. | Health Technology |
| Smead Funds Trust | Miscellaneous |
Tessera, Inc.
Tessera, Inc. SemiconductorsElectronic Technology Tessera, Inc. provides packaging solutions for the semiconductor industry. The company was founded on December 16, 1992 and is headquartered in San Jose, CA. | Electronic Technology |
| Northwest NeuroNeighborhood |
